相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Curcumin Ameliorates Memory Decline via Inhibiting BACE1 Expression and β-Amyloid Pathology in 5xFAD Transgenic Mice
Kunmu Zheng et al.
MOLECULAR NEUROBIOLOGY (2017)
Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells
Ghislain Djiokeng Paka et al.
MOLECULAR PHARMACEUTICS (2017)
Curcumin, a Compound from Natural Sources, a True Scientific Challenge - A Review
Zorka Stanic
PLANT FOODS FOR HUMAN NUTRITION (2017)
The Mechanisms of Action of Curcumin in Alzheimer's Disease
Mengxi Tang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes
Sarah Urnauer et al.
JOURNAL OF GENE MEDICINE (2017)
TDP-43 expression influences amyloidβ plaque deposition and tau aggregation
Stephani A. Davis et al.
NEUROBIOLOGY OF DISEASE (2017)
Curcumin administration suppress acetylcholinesterase gene expression in cadmium treated rats
Ayodele Jacob Akinyemi et al.
NEUROTOXICOLOGY (2017)
Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ1-42-induced oxidative stress
Faiz Ul Amin et al.
JOURNAL OF NANOBIOTECHNOLOGY (2017)
Physiological Functions of the β-Site Amyloid Precursor Protein Cleaving Enzyme 1 and 2
Riqiang Yan
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model
Wang-Sheng Jin et al.
ACTA NEUROPATHOLOGICA (2017)
Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of Type 1 diabetes mellitus
Raghu Ganugula et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Molecular Pathogenesis of Alzheimer's Disease: An Update
Alfredo Sanabria-Castro et al.
ANNALS OF NEUROSCIENCES (2017)
Preventive effect of genetic knockdown and pharmacological blockade of CysLT1R on lipopolysaccharide (LPS)-induced memory deficit and neurotoxicity in vivo
Fang Chen et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease
K. G. Goozee et al.
BRITISH JOURNAL OF NUTRITION (2016)
Graphene quantum dots conjugated neuroprotective peptide improve learning and memory capability
Songhua Xiao et al.
BIOMATERIALS (2016)
Curcumin ameliorates insulin signalling pathway in brain of Alzheimer's disease transgenic mice
Hui-li Feng et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2016)
Synthesis, characterisation and preliminary investigation of the haemocompatibility of polyethyleneimine-grafted carboxymethyl chitosan for gene delivery
Xuan Liu et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2016)
Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking
Pawan Kumar Pandey et al.
TISSUE BARRIERS (2016)
Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease
Tiantian Yin et al.
ACTA BIOMATERIALIA (2015)
Rodent models for Alzheimer's disease drug discovery
Daniela Puzzo et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
The Stability, Sustained Release and Cellular Antioxidant Activity of Curcumin Nanoliposomes
Xing Chen et al.
MOLECULES (2015)
NEURODEGENERATION Amyloid-β-pathology induced in humans
Mathias Jucker et al.
NATURE (2015)
Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits
Shu-Sheng Jiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Biological and therapeutic activities, and anticancer properties of curcumin (Review)
Donatella Perrone et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy
Shengnuo Fan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment
Ornchuma Naksuriya et al.
BIOMATERIALS (2014)
Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease
Lan Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway
Han-Chang Huang et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide
Zhongyang Liu et al.
BIOCONJUGATE CHEMISTRY (2013)
Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats
Najeh Maissar Khalil et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease
Rocio Perez-Gonzalez et al.
NEUROBIOLOGY OF AGING (2013)
Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor
Roger Prades et al.
BIOMATERIALS (2012)
Preparation and characterization of cationic curcumin nanoparticles for improvement of cellular uptake
Jinsong Liu et al.
CARBOHYDRATE POLYMERS (2012)
Curcumin loaded mixed micelles composed of Pluronic P123 and F68: Preparation, optimization and in vitro characterization
Liyan Zhao et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2012)
Curcumin Binds to Aβ1-40 Peptides and Fibrils Stronger Than Ibuprofen and Naproxen
Son Tung Ngo et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2012)
Nanobiotechnology-based strategies for crossing the blood-brain barrier
Kewal K. Jain
NANOMEDICINE (2012)
Protective Effects of Curcumin on Amyloid-β-Induced Neuronal Oxidative Damage
Han-Chang Huang et al.
NEUROCHEMICAL RESEARCH (2012)
Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease
Anila Mathew et al.
PLOS ONE (2012)
Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides
Jingwei Li et al.
BIOMATERIALS (2011)
Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles
A. Anitha et al.
CARBOHYDRATE POLYMERS (2011)
Hollow microcapsules built by layer by layer assembly for the encapsulation and sustained release of curcumin
S. Manju et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2011)
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems-A review
Susanne Fredenberg et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Amyloid-beta(42) Activates the Expression of BACE1 Through the JNK Pathway
Michela Guglielmotto et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo
Zhimei Song et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2011)
Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain
Inge van Rooy et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Dual-targeted polyplexes: One step towards a synthetic virus for cancer gene therapy
Yu Nie et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Curcumin and Alzheimer's Disease
Tsuyoshi Hamaguchi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Synaptic degeneration in Alzheimer's disease
Thomas Arendt
ACTA NEUROPATHOLOGICA (2009)
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer
J. Shaikh et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Dennis J. Selkoe
BEHAVIOURAL BRAIN RESEARCH (2008)
Disease-modifying therapies for Alzheimer disease
Jeffrey L. Cummings et al.
NEUROLOGY (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Ubiquitin hydrolase Uch-L1 rescues β-amyloid-induced decreases in synaptic function and contextual memory
Bing Gong et al.
CELL (2006)
Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro
CC Visser et al.
JOURNAL OF DRUG TARGETING (2004)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease
C Schwab et al.
EXPERIMENTAL NEUROLOGY (2004)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
Recombinant human adenovirus: Targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium
HB Xia et al.
JOURNAL OF VIROLOGY (2000)
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
RA Jain
BIOMATERIALS (2000)
分享论文
